PUBLISHER: The Business Research Company | PRODUCT CODE: 1648795
PUBLISHER: The Business Research Company | PRODUCT CODE: 1648795
E-pharmacy refers to a business model that operates similarly to traditional pharmacies in that it deals with the preparation and sale of prescription and over-the-counter medications. On the other hand, internet pharmacies accept online orders and mail the medications to the customer. E-pharmacy allows patients to refill prescriptions and receive over-the-counter and specialized medications.
The main types of drugs in e-pharmacy are prescription drugs and over-the-counter (OTC) drugs. Prescription drugs are used in the diagnosis, cure, mitigation, treatment, or prevention of disease. The prescription drug can only be used under the supervision of a medical professional who is legally permitted to do so. The different product types include skin care, dental, cold and flu, vitamins, weight loss, and others. The various payment methods include cash on delivery, and online payment, and involve several platforms such as app-based, and web-based.
The e-pharmacy market research report is one of a series of new reports from The Business Research Company that provides e-pharmacy market statistics, including e-pharmacy industry global market size, regional shares, competitors with an e-pharmacy market share, detailed e-pharmacy market segments, market trends and opportunities, and any further data you may need to thrive in the e-pharmacy industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The e-pharmacy market size has grown exponentially in recent years. It will grow from $109.25 billion in 2024 to $131.64 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to internet penetration and e-commerce growth, increased chronic disease incidences, aging population and healthcare needs, regulatory support for e-pharmacy, consumer convenience and time savings.
The e-pharmacy market size is expected to see exponential growth in the next few years. It will grow to $303.34 billion in 2029 at a compound annual growth rate (CAGR) of 23.2%. The growth in the forecast period can be attributed to rising adoption of telemedicine, increased focus on rural and remote healthcare access, growth of online prescription services, expanding e-commerce infrastructure, expansion of e-pharmacy services in rural areas. Major trends in the forecast period include integration of virtual health consultations, expansion of prescription delivery services, personalized medication management apps, blockchain technology for supply chain transparency, cross-border e-pharmacy operations.
The rapid growth of digital health is expected to drive the expansion of the e-pharmacy market in the future. Digital health technologies and e-pharmacy services utilize computing platforms, networks, software, and sensors for healthcare and related applications, including mobile health (mHealth), health information technology (IT), wearable devices, telehealth, telemedicine, and personalized medicine. These technologies can be applied to a wide range of purposes, from general wellness to medical equipment. For instance, in August 2022, the Australian Digital Health Agency, a government entity, reported that between 13 March 2020 and 31 July 2022, 118.2 million telehealth services were provided to 18 million patients, with over 95,000 practitioners utilizing telehealth services in 2022. Thus, the rise of digital health is fueling the growth of the e-pharmacy market.
The increasing internet penetration is expected to propel the growth of the e-pharmacy market in the coming years. The internet is an enormous worldwide network that links billions of computers all around the world and enables the transmission and transfer of information across geographical boundaries using various electronic devices. The internet, providing the foundation of e-pharmacy platforms, enables a more effective, readily available, and easy-to-use experience in accessing pharmaceuticals and healthcare services. For instance, in 2022, according to The GSM Association, a UK-based non-profit business association that represents mobile network operators worldwide, the total number of people using mobile internet has risen to 4. 6 billion (57 % of the global population). Therefore, the increasing internet penetration is driving the e-pharmacy market.
Leading companies in the e-pharmacy market are utilizing digital technology to improve patient access to medications by offering services such as home delivery, telehealth consultations, and personalized medication management, thereby increasing healthcare convenience and adherence. LillyDirect is a distinctive digital healthcare platform developed by Eli Lilly that provides personalized disease management resources, telehealth services, and direct home delivery of medications, designed to simplify access to healthcare for patients with chronic conditions like obesity, migraine, and diabetes. For example, in January 2024, Eli Lilly and Company, a U.S.-based pharmaceutical company, introduced LillyDirect, a new digital healthcare platform for U.S. patients living with obesity, migraine, and diabetes. LillyDirect includes a feature called LillyDirect Pharmacy Solutions, which enables patients to order select Lilly medications online, with these medications delivered directly to their homes through partnered online pharmacy services, enhancing user convenience.
Major companies operating in the e-pharmacy market are focusing on producing innovative products, such as e-pharmacy apps, to better meet the needs of their existing consumers. E-pharmacy apps are mobile programs or software platforms that enable the purchase, distribution, and use of pharmaceutical items and healthcare services via the Internet. For instance, in June 2023, Sun Life Health, a Canada-based health solutions company, launched the Lumino Health Pharmacy app. Sun Life customers will have the convenience of pharmacy services at their fingertips owing to the Lumino Health Pharmacy app. The characteristic features include access to a genuine pharmacist via chat or phone call. Medications are delivered directly to the home the same day or the following working day. Personalized pre-packaging to ensure that the correct prescriptions are taken at the precise time. The app allows users to track consumption, manage refills, and get vital notifications.
In February 2022, Douglas GmbH, a Germany-based retail company, acquired Disapo.de Apotheke B.V. for an undisclosed amount. Through this acquisition, Douglas seeks to strengthen its digital platform and broaden its offerings in the beauty and health sectors, enabling it to provide access to both over-the-counter and prescription medications as the e-prescription market expands in Germany. Disapo is a Netherlands-based online pharmacy that supplies prescription and non-prescription pharmaceuticals, dietary supplements, and milk powder.
Major companies operating in the e-pharmacy market include Walgreen Company, Express Scripts Holding Company, CVS Health Corporation, DocMorris N. V, OptumRx Holdings LLC, PharmEasy, Tata 1mg, Netmeds, Amazon Inc., Apollo Pharmacy Ltd., Rowlands Phamacy, The Kroger Co., Wal-Mart Stores Inc., Medlife International Private Limited, MedPlus Health Services Private Limited, Medikabazaar Private Limited, MedPlusMart Private Limited, MedsIndia Limited, MedsOnCall Healthcare Private Limited, MedsSure Healthcare Private Limited, MedsDelight Healthcare Private Limited, MedsBazaar Healthcare Private Limited
North America was the largest region in the e-pharmacy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the e-pharmacy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the e-pharmacy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.
The E-pharmacy market includes revenues earned by entities by taking orders online and sending the drugs to their destination by post. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
E-Pharmacy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on e-pharmacy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for e-pharmacy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The e-pharmacy market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.